Who Can Represent Patients? Advocates Worry They Are Being Pushed Out Of The Conversation

 
• By Sarah Karlin-Smith

Patient advocacy groups suggest US state and federal agencies are trying to exclude them from certain conversations due to drug industry connections and perceived bias. 

person up front sad to be left out of larger group gathering in background
Some patient advocates worry they are being excluded from some drug pricing conversations. • Source: Shutterstock

More from Pricing Debate

More from Conferences